Global Sepsis Diagnostics Market Insights, Forecast to 2028

Sepsis is a three-staged syndrome; it starts with systemic infections leading to severe sepsis and ultimately causing sepsis shock, which is regarded as a medical emergency. Population with weak immune system, which include children, older adults, and people with chronic diseases such as cancer, AIDS, diabetes, are prone to sepsis.
Sepsis occurs mainly due to bacterial, viral, and fungal infections. Gram-negative bacilli such as E. coli, P. aeruginosa, E. corrodens, and Haemophilus influenzae (which occurs mainly in neonates) are the main agents that cause infection, leading to sepsis. Other bacteria which causes sepsis are S. aureus, Streptococcus species, Enterococcus species, and Neisseria species.
Market Analysis and Insights: Global Sepsis Diagnostics Market
The global Sepsis Diagnostics market size is projected to reach US$ 528.8 million by 2028, from US$ 360.5 million in 2021, at a CAGR of 5.2% during 2022-2028.
North America is expected to command the largest share of the market in 2018, due to the growing prevalence of sepsis, fast adoption of high-end sepsis diagnostics devices, and rising government support for sepsis-related research.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Sepsis Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Sepsis Diagnostics market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Sepsis Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Sepsis Diagnostics market.
Global Sepsis Diagnostics Scope and Market Size
Sepsis Diagnostics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Sepsis Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type
Microbiology
Molecular Diagnostics
Immunoassays
Flow Cytometry
Microfluidics
Biomarkers

Segment by Application
Hospitals
Pathology & Reference Laboratories

By Company
Biomerieux
T2 Biosystems
Luminex
Becton, Dickinson
Roche
Danaher
Thermo Fisher
Bruker
Abbott
Immunexpress
Response Biomedical
Axis-Shield Diagnostics
Cytosorbents
Mitsubishi Chemical
EKF Diagnostics

By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA